{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:42:14Z","timestamp":1792788134205,"version":"4.5.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"vor","delay-in-days":87,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100001422","name":"American Society of Hematology","doi-asserted-by":"publisher","award":["HIP"],"award-info":[{"award-number":["HIP"]}],"id":[{"id":"10.13039\/100001422","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL118018, R01HL152707, R21HL157886, R21HL150723, R21HL152148, and K24HL167127"],"award-info":[{"award-number":["R01HL118018, R01HL152707, R21HL157886, R21HL150723, R21HL152148, and K24HL167127"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"American Heart Association","award":["849569 and 869105"],"award-info":[{"award-number":["849569 and 869105"]}],"id":[{"id":"https:\/\/ror.org\/013kjyp64","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"DOI":"10.1186\/s13058-026-02350-4","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T16:53:04Z","timestamp":1784652784000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The association between adiposity and cardiac function in patients with early breast cancer receiving cardiotoxic therapies"],"prefix":"10.1186","volume":"28","author":[{"given":"Gabriel","family":"Aleixo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei Ting","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wonyoung","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Congying","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Narayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehoda M.","family":"Martei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramy","family":"Sedhom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Witschey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonnie","family":"Ky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,21]]},"reference":[{"issue":"6","key":"2350_CR1","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1097\/CCO.0000000000000991","volume":"35","author":"O Amato","year":"2023","unstructured":"Amato O, Guarneri V, Girardi F. Epidemiology trends and progress in breast cancer survival: earlier diagnosis, new therapeutics. Curr Opin Oncol. 2023;35(6):612\u20139. https:\/\/doi.org\/10.1097\/CCO.0000000000000991.","journal-title":"Curr Opin Oncol"},{"issue":"6","key":"2350_CR2","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.jaccao.2024.08.008","volume":"6","author":"O Calvillo-Arguelles","year":"2024","unstructured":"Calvillo-Arguelles O, Thavendiranathan P, Chen Y, et al. Incident myocardial infarction, heart failure, and oncologic outcomes in breast cancer survivors. JACC CardioOncology. 2024;6(6):893\u2013903. https:\/\/doi.org\/10.1016\/j.jaccao.2024.08.008.","journal-title":"JACC CardioOncology"},{"issue":"8","key":"2350_CR3","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1200\/JCO.2016.70.5400","volume":"35","author":"SH Armenian","year":"2017","unstructured":"Armenian SH, Lacchetti C, Barac A, et al. Prevention and monitoring of cardiac dysfunction in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol. 2017;35(8):893\u2013911. https:\/\/doi.org\/10.1200\/JCO.2016.70.5400.","journal-title":"J Clin Oncol"},{"issue":"3","key":"2350_CR4","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.jaccao.2025.01.009","volume":"7","author":"L Daniel","year":"2025","unstructured":"Daniel L, Bellissimo MP, D\u2019Agostino RB Jr, et al. Intermuscular fat and physical activity levels relative to exercise capacity change during breast cancer treatment. JACC CardioOncol. 2025;7(3):297\u20139. https:\/\/doi.org\/10.1016\/j.jaccao.2025.01.009.","journal-title":"JACC CardioOncol"},{"issue":"4","key":"2350_CR5","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1001\/jamacardio.2018.0022","volume":"3","author":"SS Khan","year":"2018","unstructured":"Khan SS, Ning H, Wilkins JT, et al. Association of body mass index with lifetime risk of cardiovascular disease and compression of morbidity. JAMA Cardiol. 2018;3(4):280\u20137. https:\/\/doi.org\/10.1001\/jamacardio.2018.0022.","journal-title":"JAMA Cardiol"},{"key":"2350_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph21060757","author":"Y Wu","year":"2024","unstructured":"Wu Y, Li D, Vermund SH. Advantages and limitations of the body mass index (BMI) to assess adult obesity. Int J Environ Res Public Health. 2024. https:\/\/doi.org\/10.3390\/ijerph21060757.","journal-title":"Int J Environ Res Public Health"},{"issue":"5","key":"2350_CR7","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1097\/MCO.0000000000000395","volume":"20","author":"MC Gonzalez","year":"2017","unstructured":"Gonzalez MC, Correia M, Heymsfield SB. A requiem for BMI in the clinical setting. Curr Opin Clin Nutr Metab Care. 2017;20(5):314\u201321. https:\/\/doi.org\/10.1097\/MCO.0000000000000395.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"5","key":"2350_CR8","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.jacc.2022.11.031","volume":"81","author":"RG Bianchettin","year":"2023","unstructured":"Bianchettin RG, Lavie CJ, Lopez-Jimenez F. Challenges in cardiovascular evaluation and management of obese patients: JACC state-of-the-art review. J Am Coll Cardiol. 2023;81(5):490\u2013504. https:\/\/doi.org\/10.1016\/j.jacc.2022.11.031.","journal-title":"J Am Coll Cardiol"},{"issue":"20","key":"2350_CR9","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1161\/CIRCULATIONAHA.123.064071","volume":"147","author":"AA Damluji","year":"2023","unstructured":"Damluji AA, Alfaraidhy M, AlHajri N, et al. Sarcopenia and cardiovascular diseases. Circulation. 2023;147(20):1534\u201353. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.123.064071.","journal-title":"Circulation"},{"key":"2350_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2021.101264","volume":"44","author":"K Gao","year":"2022","unstructured":"Gao K, Cao LF, Ma WZ, et al. Association between sarcopenia and cardiovascular disease among middle-aged and older adults: findings from the China health and retirement longitudinal study. EClinicalMedicine. 2022;44:101264. https:\/\/doi.org\/10.1016\/j.eclinm.2021.101264.","journal-title":"EClinicalMedicine"},{"issue":"7","key":"2350_CR11","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.jchf.2022.04.012","volume":"10","author":"K Huynh","year":"2022","unstructured":"Huynh K, Ayers C, Butler J, et al. Association between thigh muscle fat infiltration and incident heart failure: the health ABC study. JACC Heart Fail. 2022;10(7):485\u201393. https:\/\/doi.org\/10.1016\/j.jchf.2022.04.012.","journal-title":"JACC Heart Fail"},{"issue":"1","key":"2350_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-88587-9","volume":"11","author":"M Ruiz-Castell","year":"2021","unstructured":"Ruiz-Castell M, Samouda H, Bocquet V, Fagherazzi G, Stranges S, Huiart L. Estimated visceral adiposity is associated with risk of cardiometabolic conditions in a population based study. Sci Rep. 2021;11(1):9121. https:\/\/doi.org\/10.1038\/s41598-021-88587-9.","journal-title":"Sci Rep"},{"issue":"11","key":"2350_CR13","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1016\/j.jacc.2021.07.014","volume":"78","author":"A Pandey","year":"2021","unstructured":"Pandey A, Shah SJ, Butler J, et al. Exercise intolerance in older adults with heart failure with preserved ejection fraction: JACC state-of-the-art review. J Am Coll Cardiol. 2021;78(11):1166\u201387. https:\/\/doi.org\/10.1016\/j.jacc.2021.07.014.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"2350_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-024-19358-0","volume":"24","author":"H Emamat","year":"2024","unstructured":"Emamat H, Jamshidi A, Farhadi A, Ghalandari H, Ghasemi M, Tangestani H. The association between the visceral to subcutaneous abdominal fat ratio and the risk of cardiovascular diseases: a systematic review. BMC Public Health. 2024;24(1):1827. https:\/\/doi.org\/10.1186\/s12889-024-19358-0.","journal-title":"BMC Public Health"},{"issue":"15","key":"2350_CR15","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1161\/CIRCULATIONAHA.117.032474","volume":"137","author":"M Packer","year":"2018","unstructured":"Packer M. Leptin-aldosterone-neprilysin axis: identification of its distinctive role in the pathogenesis of the three phenotypes of heart failure in people with obesity. Circulation. 2018;137(15):1614\u201331. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.117.032474.","journal-title":"Circulation"},{"issue":"16","key":"2350_CR16","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/j.jacc.2025.06.055","volume":"86","author":"M Packer","year":"2025","unstructured":"Packer M. The adipokine hypothesis of heart failure with a preserved ejection fraction: a novel framework to explain pathogenesis and guide treatment. J Am Coll Cardiol. 2025;86(16):1269\u2013373. https:\/\/doi.org\/10.1016\/j.jacc.2025.06.055.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"2350_CR17","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jaccao.2023.11.005","volume":"6","author":"SJ Foulkes","year":"2024","unstructured":"Foulkes SJ, Haykowsky MJ, Li T, et al. Determinants of impaired peak oxygen uptake in breast cancer survivors: JACC: cardioOncology primer. JACC CardioOncology. 2024;6(1):33\u20137. https:\/\/doi.org\/10.1016\/j.jaccao.2023.11.005.","journal-title":"JACC CardioOncology"},{"issue":"1","key":"2350_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-93241-5","volume":"11","author":"AA Kirkham","year":"2021","unstructured":"Kirkham AA, Haykowsky MJ, Beaudry RI, et al. Cardiac and skeletal muscle predictors of impaired cardiorespiratory fitness post-anthracycline chemotherapy for breast cancer. Sci Rep. 2021;11(1):14005. https:\/\/doi.org\/10.1038\/s41598-021-93241-5.","journal-title":"Sci Rep"},{"issue":"10","key":"2350_CR19","doi-asserted-by":"publisher","first-page":"5495","DOI":"10.1096\/fj.201700968R","volume":"32","author":"S Mijwel","year":"2018","unstructured":"Mijwel S, Cardinale DA, Norrbom J, et al. Exercise training during chemotherapy preserves skeletal muscle fiber area, capillarization, and mitochondrial content in patients with breast cancer. FASEB J. 2018;32(10):5495\u2013505. https:\/\/doi.org\/10.1096\/fj.201700968R.","journal-title":"FASEB J"},{"issue":"3","key":"2350_CR20","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.jaccao.2023.01.006","volume":"5","author":"MP Bellissimo","year":"2023","unstructured":"Bellissimo MP, Reding KW, O\u2019Connell NS, et al. Intermuscular fat changes are related to reduced left ventricular ejection fraction during cancer therapy (PREVENT-WF-98213). JACC CardioOncol. 2023;5(3):409\u201311. https:\/\/doi.org\/10.1016\/j.jaccao.2023.01.006.","journal-title":"JACC CardioOncol"},{"issue":"4","key":"2350_CR21","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1136\/bmjspcare-2021-003197","volume":"13","author":"O Bas","year":"2023","unstructured":"Bas O, Erdemir AG, Onur MR, et al. Sarcopenia and anthracycline cardiotoxicity in patients with cancer. BMJ Support Palliat Care. 2023;13(4):453\u201361. https:\/\/doi.org\/10.1136\/bmjspcare-2021-003197.","journal-title":"BMJ Support Palliat Care"},{"issue":"17","key":"2350_CR22","doi-asserted-by":"publisher","first-page":"6122","DOI":"10.1002\/cam4.3277","volume":"9","author":"JN Upshaw","year":"2020","unstructured":"Upshaw JN, Hubbard RA, Hu J, et al. Physical activity during and after breast cancer therapy and associations of baseline physical activity with changes in cardiac function by echocardiography. Cancer Med. 2020;9(17):6122\u201331. https:\/\/doi.org\/10.1002\/cam4.3277.","journal-title":"Cancer Med"},{"issue":"5","key":"2350_CR23","doi-asserted-by":"publisher","DOI":"10.1148\/ryai.230024","volume":"5","author":"J Wasserthal","year":"2023","unstructured":"Wasserthal J, Breit HC, Meyer MT, et al. TotalSegmentator: robust segmentation of 104 anatomic structures in CT images. Radiol Artif Intell. 2023;5(5):e230024. https:\/\/doi.org\/10.1148\/ryai.230024.","journal-title":"Radiol Artif Intell"},{"issue":"6","key":"2350_CR24","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1001\/jamaoncol.2018.0137","volume":"4","author":"BJ Caan","year":"2018","unstructured":"Caan BJ, Cespedes Feliciano EM, Prado CM, et al. Association of muscle and adiposity measured by computed tomography with survival in patients with nonmetastatic breast cancer. JAMA Oncol. 2018;4(6):798\u2013804. https:\/\/doi.org\/10.1001\/jamaoncol.2018.0137.","journal-title":"JAMA Oncol"},{"issue":"3","key":"2350_CR25","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s10549-020-05731-1","volume":"182","author":"GFP Aleixo","year":"2020","unstructured":"Aleixo GFP, Shachar SS, Deal AM, et al. The association of body composition parameters and adverse events in women receiving chemotherapy for early breast cancer. Breast Cancer Res Treat. 2020;182(3):631\u201342. https:\/\/doi.org\/10.1007\/s10549-020-05731-1.","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"2350_CR26","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.jaccao.2025.01.012","volume":"7","author":"E Berlin","year":"2025","unstructured":"Berlin E, Ko K, Ma L, et al. Cardiac effects of modern breast radiation therapy in patients receiving systemic cancer therapy. JACC CardioOnc. 2025;7(3):219\u201330. https:\/\/doi.org\/10.1016\/j.jaccao.2025.01.012.","journal-title":"JACC CardioOnc"},{"issue":"12","key":"2350_CR27","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1093\/ehjci\/jew082","volume":"17","author":"SF Nagueh","year":"2016","unstructured":"Nagueh SF, Smiseth OA, Appleton CP, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2016;17(12):1321\u201360. https:\/\/doi.org\/10.1093\/ehjci\/jew082.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"2","key":"2350_CR28","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.014708","volume":"9","author":"BG Demissei","year":"2020","unstructured":"Demissei BG, Hubbard RA, Zhang L, et al. Changes in cardiovascular biomarkers with breast cancer therapy and associations with cardiac dysfunction. J Am Heart Assoc. 2020;9(2):e014708. https:\/\/doi.org\/10.1161\/JAHA.119.014708.","journal-title":"J Am Heart Assoc"},{"issue":"7","key":"2350_CR29","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.echo.2025.03.011","volume":"38","author":"SF Nagueh","year":"2025","unstructured":"Nagueh SF, Sanborn DY, Oh JK, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography and for heart failure with preserved ejection fraction diagnosis: an update from the American Society of Echocardiography. J Am Soc Echocardiogr. 2025;38(7):537\u201369. https:\/\/doi.org\/10.1016\/j.echo.2025.03.011.","journal-title":"J Am Soc Echocardiogr"},{"issue":"16","key":"2350_CR30","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1016\/j.jacc.2022.08.743","volume":"80","author":"LA Baldassarre","year":"2022","unstructured":"Baldassarre LA, Ganatra S, Lopez-Mattei J, et al. Advances in multimodality imaging in cardio-oncology: JACC state-of-the-art review. J Am Coll Cardiol. 2022;80(16):1560\u201378. https:\/\/doi.org\/10.1016\/j.jacc.2022.08.743.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"2350_CR31","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.jaccao.2025.03.008","volume":"7","author":"FI Mulder","year":"2025","unstructured":"Mulder FI, Horvath-Puho E, van Es N, et al. Risk of cardiovascular disease in cancer survivors after systemic treatment: a population-based cohort study. JACC CardioOncol. 2025;7(4):360\u201378. https:\/\/doi.org\/10.1016\/j.jaccao.2025.03.008.","journal-title":"JACC CardioOncol"},{"issue":"1","key":"2350_CR32","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1161\/CIRCULATIONAHA.116.026807","volume":"136","author":"M Obokata","year":"2017","unstructured":"Obokata M, Reddy YNV, Pislaru SV, Melenovsky V, Borlaug BA. Evidence supporting the existence of a distinct obese phenotype of heart failure with preserved ejection fraction. Circulation. 2017;136(1):6\u201319. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.116.026807.","journal-title":"Circulation"},{"issue":"1","key":"2350_CR33","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.jaccao.2025.12.002","volume":"8","author":"I Landsteiner","year":"2026","unstructured":"Landsteiner I, Foulkes SJ, Campain J, et al. Reduced exercise capacity in breast cancer compared to HFpEF: mechanistic insights from invasive exercise testing. JACC CardioOncol. 2026;8(1):80\u20132. https:\/\/doi.org\/10.1016\/j.jaccao.2025.12.002.","journal-title":"JACC CardioOncol"},{"issue":"7","key":"2350_CR34","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1093\/cvr\/cvy038","volume":"114","author":"O Sorop","year":"2018","unstructured":"Sorop O, Heinonen I, van Kranenburg M, et al. Multiple common comorbidities produce left ventricular diastolic dysfunction associated with coronary microvascular dysfunction, oxidative stress, and myocardial stiffening. Cardiovasc Res. 2018;114(7):954\u201364. https:\/\/doi.org\/10.1093\/cvr\/cvy038.","journal-title":"Cardiovasc Res"},{"issue":"Suppl 3","key":"2350_CR35","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1159\/000074502","volume":"60","author":"Y Matsuzawa","year":"2003","unstructured":"Matsuzawa Y, Shimomura I, Kihara S, Funahashi T. Importance of adipocytokines in obesity-related diseases. Horm Res. 2003;60(Suppl 3):56\u20139. https:\/\/doi.org\/10.1159\/000074502.","journal-title":"Horm Res"},{"issue":"25","key":"2350_CR36","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1093\/eurheartj\/ehaf057","volume":"46","author":"A Peikert","year":"2025","unstructured":"Peikert A, Vaduganathan M, Claggett BL, et al. Near-universal prevalence of central adiposity in heart failure with preserved ejection fraction: the PARAGON-HF trial. Eur Heart J. 2025;46(25):2372\u201390. https:\/\/doi.org\/10.1093\/eurheartj\/ehaf057.","journal-title":"Eur Heart J"},{"issue":"6","key":"2350_CR37","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.3945\/ajcn.2009.28141","volume":"90","author":"C Li","year":"2009","unstructured":"Li C, Ford ES, Zhao G, Balluz LS, Giles WH. Estimates of body composition with dual-energy X-ray absorptiometry in adults. Am J Clin Nutr. 2009;90(6):1457\u201365. https:\/\/doi.org\/10.3945\/ajcn.2009.28141.","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"2350_CR38","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s10549-010-1223-2","volume":"125","author":"GJ van Londen","year":"2011","unstructured":"van Londen GJ, Perera S, Vujevich K, et al. The impact of an aromatase inhibitor on body composition and gonadal hormone levels in women with breast cancer. Breast Cancer Res Treat. 2011;125(2):441\u20136. https:\/\/doi.org\/10.1007\/s10549-010-1223-2.","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"2350_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0151548","volume":"11","author":"LA Biondo","year":"2016","unstructured":"Biondo LA, Lima Junior EA, Souza CO, et al. Impact of doxorubicin treatment on the physiological functions of white adipose tissue. PLoS ONE. 2016;11(3):e0151548. https:\/\/doi.org\/10.1371\/journal.pone.0151548.","journal-title":"PLoS ONE"},{"issue":"2","key":"2350_CR40","doi-asserted-by":"publisher","DOI":"10.1111\/apha.13400","volume":"229","author":"AE Hiensch","year":"2020","unstructured":"Hiensch AE, Bolam KA, Mijwel S, et al. Doxorubicin-induced skeletal muscle atrophy: elucidating the underlying molecular pathways. Acta Physiol. 2020;229(2):e13400. https:\/\/doi.org\/10.1111\/apha.13400.","journal-title":"Acta Physiol"},{"issue":"6","key":"2350_CR41","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/S2213-8587(22)00070-5","volume":"10","author":"A Gastaldelli","year":"2022","unstructured":"Gastaldelli A, Cusi K, Fernandez Lando L, Bray R, Brouwers B, Rodriguez A. Effect of tirzepatide versus insulin degludec on liver fat content and abdominal adipose tissue in people with type 2 diabetes (SURPASS-3 MRI): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial. Lancet Diabetes Endocrinol. 2022;10(6):393\u2013406. https:\/\/doi.org\/10.1016\/S2213-8587(22)00070-5.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"2350_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaccao.2025.12.003","volume":"8","author":"D Leong","year":"2026","unstructured":"Leong D, Gong S, Sattar N, et al. Incretin mimetics in cancer and cardiovascular disease: JACC: cardiooncology state-of-the-art review. JACC CardioOncol. 2026;8(1):1\u201316. https:\/\/doi.org\/10.1016\/j.jaccao.2025.12.003.","journal-title":"JACC CardioOncol"},{"key":"2350_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-026-04204-0","author":"SB Heymsfield","year":"2026","unstructured":"Heymsfield SB, Aronne LJ, Montgomery P, et al. Bimagrumab plus semaglutide alone or in combination for the treatment of obesity: a randomized phase 2 trial. Nat Med. 2026. https:\/\/doi.org\/10.1038\/s41591-026-04204-0.","journal-title":"Nat Med"},{"issue":"1","key":"2350_CR44","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1056\/NEJMoa2502760","volume":"393","author":"KS Courneya","year":"2025","unstructured":"Courneya KS, Vardy JL, O\u2019Callaghan CJ, et al. Structured exercise after adjuvant chemotherapy for colon cancer. N Engl J Med. 2025;393(1):13\u201325. https:\/\/doi.org\/10.1056\/NEJMoa2502760.","journal-title":"N Engl J Med"},{"issue":"2","key":"2350_CR45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0056415","volume":"8","author":"D Vissers","year":"2013","unstructured":"Vissers D, Hens W, Taeymans J, Baeyens JP, Poortmans J, Van Gaal L. The effect of exercise on visceral adipose tissue in overweight adults: a systematic review and meta-analysis. PLoS ONE. 2013;8(2):e56415. https:\/\/doi.org\/10.1371\/journal.pone.0056415.","journal-title":"PLoS ONE"},{"issue":"4","key":"2350_CR46","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.jaccao.2025.04.006","volume":"7","author":"SH Johansen","year":"2025","unstructured":"Johansen SH, Saeter M, Sarvari SI, et al. Effects of aerobic exercise on cardiorespiratory fitness and cardiovascular risk factors in long-term breast cancer survivors: a randomized controlled trial. JACC CardioOncol. 2025;7(4):414\u201326. https:\/\/doi.org\/10.1016\/j.jaccao.2025.04.006.","journal-title":"JACC CardioOncol"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13058-026-02350-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-026-02350-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-026-02350-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T04:38:23Z","timestamp":1792125503000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13058-026-02350-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,21]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2350"],"URL":"https:\/\/doi.org\/10.1186\/s13058-026-02350-4","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,21]]},"assertion":[{"value":"19 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. The Penn Cardiotoxicity of Cancer Therapy cohort study (NCT01173341 registration date: August 2, 2010) was approved by the University of Pennsylvania Institutional Review Board (Protocol 811155). The present analysis was conducted under the same IRB approval. Written informed consent was obtained from all individual participants enrolled in the Penn Cardiotoxicity of Cancer Therapy cohort prior to participation.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Figure\u00a0\n                      \n                      displays de-identified axial CT images at the L3 vertebral level. The images contain no facial features, no body regions that could identify the participants, and no associated identifying metadata. No individually identifying participant data are reported.","order":2,"name":"Ethics","label":"Consent to publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"176"}}